Evidence map›Paper›PMID 42729962›Full record

ReviewFrontiers in neurology2026

Visual impairment in multiple sclerosis involving post-geniculate gray and white matter: above and beyond.

Xiaojun Zhang, Gordon T Plant

Abstract readReview
In one paragraph

Review in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaojun ZhangDepartment of Neurology, Department of Ophthalmology and Visual Science, The Ohio State University College of Medicine, Wexner Medical Center, Columbus, OH, United States.
Gordon T PlantDepartment of Translational Neuroscience and Stroke, University College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visual impairment is one of the most common and disabling manifestations of multiple sclerosis (MS). While visual dysfunction related to optic neuritis and brainstem involvement is well recognized, visual impairment associated with post-geniculate visual pathways-including the optic radiations and visual cortex-remains comparatively under-studied and under-recognized in clinical practice. Increasing evidence from advanced neuroimaging, optical coherence tomography, and neuropsychological testing has demonstrated that lesions affecting post-geniculate white and gray matter contribute to both symptomatic and subclinical visual dysfunction in people with multiple sclerosis (PwMS). These abnormalities include homonymous visual field defects, visuoperceptual dysfunction, visual cognitive impairment, and higher-order ocular motor abnormalities. Cortical lesions and cortical thinning correlate with deficits in visual memory, visuospatial processing, and processing speed, while optic radiation damage contributes to retrograde transsynaptic degeneration and impaired visual information processing. Emerging eye-movement paradigms further suggest that higher-order ocular motor dysfunction reflects widespread gray matter involvement and may serve as a sensitive biomarker of disease burden. This review summarizes current histopathological and imaging evidence for post-geniculate pathway involvement in MS and discusses its clinical relevance for diagnosis, monitoring, and functional assessment.

Indexed as

Geniculate BodiesGray MatterMultiple SclerosisVision DisordersVisual PathwaysWhite MatterHumanscognitive impairmentcortical atrophyMRImultiple scleorsisocular motoroptical coherance tomographypost-geniculate visual pathwayvision

Identifiers

PMID42729962
PMCPMC13563509

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.